Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by moonball32on Feb 10, 2022 12:01pm
81 Views
Post# 34416926

RE:Day 10 into February

RE:Day 10 into FebruaryYou are raising valid points. The longer the delay the more it would appear the results aren't as stellar as they have been alluded to. The clinical tests were done 10 days ago, so 30 comparables a day doesn't seem an unrealistic expectation. If no news by Tuesday I will have to seriously re-evaluate my position, at the very least adjust the stop losses. Generally news on Fridays is bad, so if nothing comes out today, even after hours, then hopefully the company releases great news early next week. Robs statements about sales from acuvid by end of first quarter are starting to fade away, it's only 6 weeks to go and no submission to FDA, and to think FDA will quickly approve the application is either very hopeful or terribly misguided.
<< Previous
Bullboard Posts
Next >>